Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

103.73USD
29 Aug 2014
Price Change (% chg)

$0.78 (+0.76%)
Prev Close
$102.95
Open
$103.10
Day's High
$103.76
Day's Low
$103.01
Volume
2,224,720
Avg. Vol
1,819,575
52-wk High
$106.74
52-wk Low
$85.50

JNJ.N

Chart for JNJ.N

About

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products... (more)

Overall

Beta: 0.59
Market Cap (Mil.): $292,548.41
Shares Outstanding (Mil.): 2,820.29
Dividend: 0.70
Yield (%): 2.70

Financials

  JNJ.N Industry Sector
P/E (TTM): 19.17 32.30 33.23
EPS (TTM): 5.41 -- --
ROI: 14.72 17.96 17.21
ROE: 21.06 18.60 18.01
Search Stocks

Johnson & Johnson to seek buyer for medical device maker unit: WSJ

- Johnson & Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.

29 Aug 2014

Johnson & Johnson to seek buyer for medical device maker unit -WSJ

Aug 28 - Johnson & Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.

29 Aug 2014

FDA says Johnson & Johnson recalls some jaw implants

- Johnson & Johnson is recalling some lots of its implant used to correct defects of the jaw, following more than a dozen cases of injury.

28 Aug 2014

UPDATE 1-FDA says Johnson & Johnson recalls some jaw implants

Aug 28 - Johnson & Johnson is recalling some lots of its implant used to correct defects of the jaw, following more than a dozen cases of injury.

28 Aug 2014

FDA says Johnson & Johnson recalls some jaw implants

Aug 28 - Johnson & Johnson is recalling some lots of its implant used to correct defects of the jaw following more than a dozen cases of injury.

28 Aug 2014

COLUMN-Healthcare: A remedy for long-term investors

(The opinions expressed here are those of the author, a columnist for Reuters.)

05 Aug 2014

J&J seeks return of device seen as possibly raising cancer risk

- Johnson & Johnson said on Wednesday it plans to ask doctors to return its power morcellators, a controversial surgical device that may inadvertently spread cancer in women being treated for uterine growths called fibroids.

31 Jul 2014

J&J seeks return of device seen as possibly raising cancer risk

July 30 - Johnson & Johnson said on Wednesday it plans to ask doctors to return its power morcellators, a controversial surgical device that may inadvertently spread cancer in women being treated for uterine growths called fibroids.

31 Jul 2014

Europe backs new leukaemia drugs from J&J and Gilead

LONDON, July 25 - Two new leukaemia drugs from Johnson & Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months.

25 Jul 2014

BRIEF-EU medicines agency backs new drugs from Novo Nordisk, J&J, Gilead

July 25 - The European Medicines Agency: * EU medicines agency says recommends Novo Nordisk diabetes

25 Jul 2014

Earnings vs. Estimates

Search Stocks